This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, studies presented at this year’s American Society of Clinical Oncology meeting highlight the ongoing advances in lung cancer treatments for earlier stages of the disease in specific populations. In addition, optimal timing of radiotherapy after radical prostatectomy points to salvage radiotherapy for prostate‐specific antigen failure, and the addition of apalutamide to androgen deprivation therapy after radical prostatectomy offers encouraging results.
No takes yet. Share an insight, caveat, or question.
Mary Beth Nierengarten (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: